DOI ISSN 2375-1924 ABSTRACT Background: Coronary artery disease (CAD) imposes marked morbidity on patients, with many afflicted with debilitating residual symptoms despite optimal application of the available medical and surgical options
Given its high usage and availability as an over-the-counter analgesic, a systematic review of paracetamols efficacy and tolerability in individual conditions is warranted (Roberts et al., 2016)
Disulfide reductase systems in liver
These include: Nausea and vomiting typically most pronounced during dose escalation and often improving with continued use Diarrhoea or constipation affecting bowel habit regularity Abdominal pain and discomfort ranging from mild cramping to more significant discomfort Dyspepsia and gastro-oesophageal reflux related to delayed gastric emptying Injection site reactions are classified as 'common' (affecting up to 1 in 10 people) and may include redness, itching, bruising, or localised swelling at the subcutaneous injection site
personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 for semaglutide)
Yoo M, Cho S, Shin S, Kim JM, Park HG, Cho S, Hwang YK, Park DH